Susquehanna Advisors Group Inc. Acquires 102,556 Shares of The Chemours Company $CC

Susquehanna Advisors Group Inc. boosted its holdings in The Chemours Company (NYSE:CC) by 74.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 241,016 shares of the specialty chemicals company’s stock after buying an additional 102,556 shares during the period. Susquehanna Advisors Group Inc.’s holdings in Chemours were worth $4,946,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of CC. Parallel Advisors LLC raised its stake in shares of Chemours by 10.9% during the 1st quarter. Parallel Advisors LLC now owns 5,366 shares of the specialty chemicals company’s stock valued at $118,000 after purchasing an additional 527 shares during the period. Oregon Public Employees Retirement Fund boosted its stake in Chemours by 1.8% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 34,300 shares of the specialty chemicals company’s stock worth $404,000 after purchasing an additional 600 shares during the period. Man Group plc boosted its stake in Chemours by 0.4% in the 2nd quarter. Man Group plc now owns 271,108 shares of the specialty chemicals company’s stock worth $3,104,000 after purchasing an additional 979 shares during the period. Rothschild Investment LLC grew its holdings in Chemours by 87.0% during the 4th quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 1,255 shares in the last quarter. Finally, Abel Hall LLC grew its holdings in Chemours by 12.6% during the 1st quarter. Abel Hall LLC now owns 12,267 shares of the specialty chemicals company’s stock valued at $270,000 after buying an additional 1,369 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Insider Transactions at Chemours

In related news, CFO Shane Hostetter acquired 3,350 shares of the stock in a transaction on Thursday, August 6th. The stock was acquired at an average cost of $14.94 per share, for a total transaction of $50,049.00. Following the completion of the acquisition, the chief financial officer directly owned 102,698 shares of the company’s stock, valued at approximately $1,534,308.12. This represents a 3.37% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Calderon Gerardo Familiar bought 1,935 shares of the stock in a transaction dated Wednesday, August 12th. The stock was purchased at an average price of $15.53 per share, with a total value of $30,050.55. Following the purchase, the insider owned 58,547 shares in the company, valued at $909,234.91. This trade represents a 3.42% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have acquired 8,663 shares of company stock worth $130,601. 0.85% of the stock is currently owned by insiders.

Chemours Stock Up 0.1%

Shares of CC opened at $15.64 on Monday. The firm has a market cap of $2.35 billion, a P/E ratio of -8.19 and a beta of 1.43. The stock has a 50 day simple moving average of $17.39 and a two-hundred day simple moving average of $19.97. The company has a debt-to-equity ratio of 18.98, a current ratio of 1.66 and a quick ratio of 0.88. The Chemours Company has a 1 year low of $10.44 and a 1 year high of $28.67.

Chemours (NYSE:CC) last issued its earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 EPS for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.07). Chemours had a positive return on equity of 60.64% and a negative net margin of 5.00%.The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the previous year, the business earned ($2.54) EPS. Chemours’s revenue for the quarter was down 1.5% compared to the same quarter last year. On average, analysts forecast that The Chemours Company will post 0.87 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Friday, August 14th will be issued a $0.0875 dividend. The ex-dividend date is Friday, August 14th. This represents a $0.35 annualized dividend and a yield of 2.2%. Chemours’s dividend payout ratio (DPR) is -18.32%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CC shares. Royal Bank Of Canada decreased their target price on shares of Chemours from $26.00 to $22.00 and set an “outperform” rating on the stock in a report on Thursday, August 6th. Mizuho set a $22.00 price target on shares of Chemours in a report on Wednesday, August 5th. UBS Group reiterated a “neutral” rating and issued a $18.00 price objective (down from $29.00) on shares of Chemours in a research report on Monday, August 10th. BMO Capital Markets dropped their price objective on Chemours from $26.00 to $18.00 and set an “outperform” rating for the company in a research note on Thursday, August 13th. Finally, Alembic Global Advisors restated an “overweight” rating and issued a $30.00 target price on shares of Chemours in a research note on Wednesday, May 13th. Five analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $20.10.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.